Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of viral inflammation and disease in humans
Jean‐Laurent Casanova, Laurent Abel
Science (2021) Vol. 374, Iss. 6571, pp. 1080-1086
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Human genetic and immunological determinants of critical COVID-19 pneumonia
Qian Zhang, Paul Bastard, Adem Karbuz, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 587-598
Open Access | Times Cited: 322
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Jérémy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 21
Open Access | Times Cited: 160
COVID-19 2022 update: transition of the pandemic to the endemic phase
Michela Biancolella, Vito Luigi Colona, Ruty Mehrian‐Shai, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 120
Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children
Danyel Lee, Jérémie Le Pen, Ahmad Yatim, et al.
Science (2022) Vol. 379, Iss. 6632
Open Access | Times Cited: 118
From rare disorders of immunity to common determinants of infection: Following the mechanistic thread
Jean‐Laurent Casanova, Laurent Abel
Cell (2022) Vol. 185, Iss. 17, pp. 3086-3103
Open Access | Times Cited: 105
Long Covid: where we stand and challenges ahead
Alberto Mantovani, Maria Concetta Morrone, Carlo Patrono, et al.
Cell Death and Differentiation (2022)
Open Access | Times Cited: 101
Human autoantibodies underlying infectious diseases
Anne Puel, Paul Bastard, Jacinta Bustamante, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 4
Open Access | Times Cited: 96
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
Qian Zhang, Daniela Matuozzo, Jérémie Le Pen, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 8
Open Access | Times Cited: 92
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Qian Zhang, Andrés Pizzorno, Lisa Miorin, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 80
Naringenin: A flavanone with anti-inflammatory and anti-infective properties
Cai Ji, Hongli Wen, He Zhou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114990-114990
Open Access | Times Cited: 80
COVID-19 and liver disease
Jean‐François Dufour, Thomas Marjot, Chiara Becchetti, et al.
Gut (2022) Vol. 71, Iss. 11, pp. 2350-2362
Closed Access | Times Cited: 71
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria
Jérémie Rosain, Anna‐Lena Neehus, Jérémy Manry, et al.
Cell (2023) Vol. 186, Iss. 3, pp. 621-645.e33
Open Access | Times Cited: 65
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Tom Le Voyer, Audrey V. Parent, Xian Liu, et al.
Nature (2023) Vol. 623, Iss. 7988, pp. 803-813
Open Access | Times Cited: 65
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients
Adrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 9
Open Access | Times Cited: 63
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Human IL-23 is essential for IFN-γ–dependent immunity to mycobacteria
Quentin Philippot, Masato Ogishi, Jonathan Bohlen, et al.
Science Immunology (2023) Vol. 8, Iss. 80
Open Access | Times Cited: 48
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 45
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 24
Pharmacological Activities of Plant‐Derived Fraxin with Molecular Mechanisms: A Comprehensive Review
Jannatul Ferdous, Md. Shimul Bhuia, Raihan Chowdhury, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 5
Closed Access | Times Cited: 18
Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Yanhong Duo, Lei Han, Yaoqiang Yang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 20, pp. 11242-11347
Open Access | Times Cited: 18
Nonresolving inflammation redux
Carl Nathan
Immunity (2022) Vol. 55, Iss. 4, pp. 592-605
Open Access | Times Cited: 65
A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes
Paul Bastard, Kuang‐Chih Hsiao, Qian Zhang, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 50
Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin
András N. Spaan, Anna‐Lena Neehus, Emmanuel Laplantine, et al.
Science (2022) Vol. 376, Iss. 6599
Open Access | Times Cited: 44
Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency
Tessa M. Campbell, Zhiyong Liu, Qian Zhang, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 7
Open Access | Times Cited: 40
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia
Ana García‐García, Rebeca Pérez de Diego, Carlos Flores, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 5
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top